Refine by
Clinical Development Services Available In Portugal
100 services found
Manufactured by:Elpiscience based inShanghai, CHINA
Elpiscience has assembled a global clinical team with a broad range of expertise from designing and leading first-in-human studies to executing large-scale global registration ...
Manufactured by:AB2 Bio Ltd. based inLausanne, SWITZERLAND
AB2 Bio has developed the first and proprietary assay to detect and measure free IL-18 in body fluids, which gives us the capability of identifying diseases associated with free IL-18 levels. The assay could also be used as a companion diagnostic to select patients most likely to respond to treatment with ...
Manufactured by:SOFIE based inDulles, VIRGINIA (USA)
Staying true to our vision to improve patient outcomes by developing and delivering molecular diagnostics and therapeutics, SOFIE has acquired global rights for the diagnostic and companion diagnostic use of the FAPI family of compounds from University of Heidelberg, the team that invented PSMA-617 (Novartis). The FAPI family of compounds have demonstrated promising theranostic ...
by:Verana Health based inSan Francisco, CAMBODIA
Verana Health’s exclusive real-world data network and clinically true Qdata™ can help accelerate clinical trials in ophthalmology, urology, and neurology—from study startup through recruitment. From protocol development and clinical trial design to site selection and identifying potential participants*, we help ...
by:Novadiscovery based inLyon, FRANCE
Explore various regimens (dose, number of administrations per day, time between administrations, duration of treatment). Identify subgroups of optimal responders / theranostic biomarkers. Leverage real-world data to inform clinical trial ...
by:PathAI, Inc. based inBoston, MASSACHUSETTS (USA)
Enable clinical trial success powered by our trial-ready algorithms, comprehensive lab services, and experienced clinical operations ...
by:Oncodesign based inDijon, FRANCE
Complementary expertise for successful progress at each stage of your development. After the discovery and proof-of-concept phases, the preclinical development of new therapeutic entities is a critical step for the regulatory approval of the first-in-man administration and the transition to the early phases of clinical trials. D-VLOP, a network ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
Pluristem’s goal is to provide patients, physicians and healthcare systems around the globe with standardized, easy to use and highly effective PLX cell products that need no genetic or tissue matching prior to administration. We are active with many respectful regulatory agencies worldwide to advance our clinical programs towards marketing. Part of our ...
by:Latham BioPharm Group based inElkridge, MARYLAND (USA)
Moving products into clinical development is a key milestone that not only creates organizational value, but, more importantly, advances them closer towards commercialization, where they can serve the patients who need them the most. Once in the clinic, progressing through clinical trials is a complex endeavor that requires ...
by:International Drug Development Institute (IDDI) based inLouvain-la-Neuve, BELGIUM
Aiming at optimizing your clinical development strategy, our expert consultants develop the innovative strategies and capabilities needed to launch products with the greatest potential for commercial success and improved patient outcomes. ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
Femoral neck fracture is the most common form of hip fracture with annual treatment costs in the U.S. estimated to be between $10 to $15 billion, and are expected to rise due to the aging population, with mortality rates of up to 36%. *click for further information about Muscle injury due to total hip ...
Manufactured by:Destiny Pharma plc based inBrighton, UNITED KINGDOM
The company is focused on the clinical development and commercial exploitation through partnering of its highly innovative anti-infective portfolio and has an open door policy to discussing potential business relationships. These range from partnering and licensing through to investment and non-dilutive funding as well as risk sharing and joint ventures with ...
Distributed by:Avicanna Inc. based inToronto, ONTARIO (CANADA)
Advanced scientific platform for drug delivery, pre-clinical and clinical development. Team of 10+ scientists, deploying optimized proprietary methodologies in extraction, formulation development, analytical testing, pre-clinical models, and clinical development. Comprehensive IP ...
by:Genmab A/S based inCopenhagen V, DENMARK
Using our antibody expertise to transform how cancer is treated; As a leader in the discovery and development of antibody therapeutics, we are inspired by nature, passionate about innovation and driven by data. Our commitment to patients pushes us to use our antibody biology expertise to pursue and produce differentiated, next-generation cancer treatments. Our research and ...
Manufactured by:Jubilant Therapeutics Inc. based inBedminster, NEW JERSEY (USA)
Jubilant Therapeutics is open for partnering or strategic. collaborations with biotech, pharma, academia, research labs for: Accelerating clinical development and market launch of our ongoing programs. Discovery/development of new programs in synergistic areas. Conducting research with our drug candidates either as monotherapy or in combination ...
Manufactured by:Atriva Therapeutics GmbH based inTübingen, GERMANY
The company’s lead drug candidate is the MEK inhibitor zapnometinib. The small molecule, which can be administered orally (tablet), is under advanced clinical development in two severe respiratory viral diseases: COVID-19 and influenza, two disease areas with urgent need for effective ...
Manufactured by:Sartorius AG based inGoettingen, GERMANY
A more seamless transition into the clinic. Complex biopharmaceuticals and advanced therapies can present challenges during preclinical development. When implementing an albumin-based solution, Albumedix can help avoid unnecessary complications in your preclinical testing by creating species-specific recombinant albumins to suit your preclinical models. ...
by:Revvity Gene Delivery (formerly SIRION Biotech) based inHamburg, GERMANY
In the discovery of oncology therapeutics, Antibody-drug conjugates (ADCs) are rapidly gaining momentum, with hundreds of candidates advancing through clinical development. Whether your priority lies in assessing the epitope binding of your construct, evaluating the cytotoxic potency of the payload, or scrutinizing the efficacy of the linker in cleaving, each ...
Manufactured by:Bracco Spa based inMilan, ITALY
For years the Bracco Group has been investing substantial resources in research, pre-clinical and clinical development of Imaging Agents for in vivo imaging. IA are used with special equipment to provide physicians with detailed information for diagnoses and to monitor minimally invasive operating procedures. Technological advances in equipment, ...
by:Patheon Inc. based inDurham, NORTH CAROLINA (USA)
Broad experience and access to the latest technological capabilities are essential for today’s increasingly complex API development and manufacturing. By partnering with Thermo Fisher Scientific, you’ll work directly with scientists with deep chemistry knowledge and many years of experience in successfully supporting early and later phase clinical ...